Myriad Genetics Inc

MYGN

Exchange: Nasdaq
Industry: In Vitro & In Vivo Diagnostic Substances
SEC CIK: 0000899923

SEC filings (opens in a new tab)

No open-market purchases or sales by Myriad Genetics Inc insiders were filed in the last 90 days; 196 institutions reported holding it in 13F filings for Q2 2026, worth $507.8M in total; no superinvestor holds it.

Q2 2021 vs. Q1 2021

How the institutions holding Myriad Genetics Inc changed between Q1 2021 and Q2 2021.

All holders in Q2 2021 All holders in Q1 2021

13F holders of MYGN: Q1 2021 compared with Q2 2021
Measure	Q1 2021	Of which not filed for Q2 2021	Q2 2021	Change
Holders	197	1	201	+5
Shares	73.9M	136.0K	75.5M	+1.76M (+2.4%)
Value	$2.25B	$4.14M	$2.31B	+$64.1M (+2.9%)

1 institution that held it in Q1 2021 haven't filed for Q2 2021 yet. Not filing isn't selling, so the changes leave them out.

New holders (27)

Institutions that held Myriad Genetics Inc at the end of Q2 2021 but not at the end of Q1 2021.

Institutions new to MYGN in Q2 2021
Institution	Shares	Value	% of portfolio
Artisan Partners Limited Partnership	1,113,599	$34.1M	0.04%
Eagle Asset Management Inc	348,281	$10.7M	0.05%
M&G Investment Management Ltd	212,774	$6.60M	0.03%
Edgestream Partners, L.P.	158,855	$4.86M	0.29%
Panagora Asset Management Inc	146,279	$4.47M	0.02%
Amundi	136,000	$4.16M	0.00%
Phocas Financial Corp.	107,699	$3.29M	0.41%
Renaissance Technologies LLC	71,674	$2.19M	0.00%
Man Group plc	71,100	$2.17M	0.01%
Hillsdale Investment Management Inc.	40,000	$1.22M	0.10%
Amalgamated Bank	37,849	$1.16M	0.01%
Assenagon Asset Management S.A.	18,036	$552.0K	0.00%
Privium Fund Management (UK) Ltd	14,000	$428.0K	0.30%
Old Mission Capital LLC	10,463	$320.0K	0.01%
Raymond James & Associates	9,594	$293.0K	0.00%
GWM Advisors LLC	8,548	$261.0K	0.01%
Vident Investment Advisory, LLC	6,689	$205.0K	0.01%
Parisi Gray Wealth Management	4,340	$133.0K	0.05%
US Bancorp	2,588	$79.0K	0.00%
Lazard Asset Management LLC	1,774	$54.0K	0.00%
FORA Capital, LLC	1,027	$31.0K	0.01%
Cullen/Frost Bankers, Inc.	856	$26.0K	0.00%
Quantbot Technologies LP	634	$19.0K	0.00%
BBVA USA	300	$9.00K	0.00%
Sageworth Trust Co	300	$9.00K	0.00%
Sonora Investment Management, LLC	260	$8.00K	0.00%
Group One Trading, L.P.	143	$4.00K	0.00%

Sold out (22)

Institutions that held Myriad Genetics Inc at the end of Q1 2021 and filed for Q2 2021 without it.

Institutions that sold out of MYGN in Q2 2021
Institution	Shares, Q1 2021	Value, Q1 2021
Balyasny Asset Management LLC	213,566	$6.50M
Adage Capital Partners GP, L.L.C.	150,000	$4.57M
California Public Employees Retirement System	145,900	$4.44M
Mackay Shields LLC	60,931	$1.86M
Tudor Investment Corp Et Al	55,845	$1.70M
Acadian Asset Management LLC	47,802	$1.46M
Migdal Insurance & Financial Holdings Ltd.	36,322	$1.11M
True Link Financial Advisors, LLC	23,611	$719.0K
PDT Partners, LLC	11,760	$358.0K
Brookfield Asset Management Inc.	11,438	$348.0K
XTX Topco Ltd	9,974	$304.0K
ETF Managers Group, LLC	9,405	$274.0K
Pacer Advisors, Inc.	2,510	$76.0K
Spire Wealth Management	1,950	$59.0K
Altshuler Shaham Ltd	1,341	$41.0K
Wealthcare Advisory Partners LLC	1,205	$37.0K
Northwestern Mutual Wealth Management Co	1,000	$30.0K
Point72 Hong Kong Ltd	630	$19.0K
Valeo Financial Advisors, LLC	513	$16.0K
Eudaimonia Partners, LLC	521	$16.0K
Benjamin F. Edwards & Company, Inc.	100	$3.00K
Wealthcare Capital Management LLC	43	$1.00K

Not filed for Q2 2021 yet (1)

Institutions that held Myriad Genetics Inc at the end of Q1 2021 and haven't filed a 13F for Q2 2021. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding MYGN in Q1 2021 that haven't filed for Q2 2021
Institution	Shares, Q1 2021	Value, Q1 2021
Amundi Asset Management US, Inc.	136,000	$4.14M